TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT05470153

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Continuous Positive Airway Pressure
Description: For each patient with Obstructive Sleep Apnea, titration of Continuous Positive Airway Pressure (CPAP) pressure will be performed by conventional polysomnography or using auto-CPAP equipment using a validated protocol. The CPAP device should have an hour meter recording system, so that machine-on time hours could be checked at each clinical visit.
Study: NCT06377761

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Qishen Granules
Description: One package per time, twice a day, 90 days of treatment

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: One package per time, twice a day, 90 days of treatment (the placebo was basically the same as Qishen granules in terms of appearance, shape, color, taste, etc.)
Study: NCT05415137

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efzofitimod 3 mg/kg
Description: EfzofitimodIV infusion every 4 weeks for a total of 12 doses

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efzofitimod 5 mg/kg
Description: EfzofitimodIV infusion every 4 weeks for a total of 12 doses

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo IV infusion every 4 weeks for a total of 12 doses
Study: NCT06246552

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: JTM201
Description: JTM201 20U in 0.5mL~: JTM201 will be injected via IM in 5 glabellar location 0.1mL (4U / 0.1mL) at each location

Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo 20U in 0.5mL~: Placebo will be injected via IM in 5 glabellar location 0.1mL (4U / 0.1mL) at each location
Study: NCT05564624

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Fasting mimicking diet (FMD)
Description: The ProLon(TM) Fasting Mimicking Diet regimen is a meal replacement plan that mimics water only fasting. It consists of 100% natural ingredients, which are generally regarded as safe (GRAS). It is comprised of bars, soups, and beverages aiming to achieve consistent and effective short-term calorie restriction, while providing adequate micronutrients. The very low protein and very low sugar content are essential characteristics of the diet. Complex carbohydrates and polyunsaturated fatty acids are its main components.
Study: NCT04908072

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Orbis-FundamentalVR MSICS Simulator
Description: Cataract surgery training device, using virtual reality software combined with existing gaming technology for simulated surgery
Study: NCT05719064

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Adaptive Cell Phone Support
Description: Mobile health adherence promotion based on the supportive accountability model

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Computer-Delivered Cell Phone Support
Description: Mobile health adherence promotion based on the supportive accountability model
Study: NCT05683080

Intervention type: OTHER
Intervention: Routine Clinical Care
Description: Participants completing the research study will receive routine clinical care
Study: NCT05719064

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Computer-Delivered Cell Phone Support
Description: Mobile health adherence promotion based on the supportive accountability model

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Automated Text Reminders
Description: Scheduled text reminder to take medication
Study: NCT04317417

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: EMPOWER
Description: Participants will receive weekly material for a total of 5 weeks consisting of 1-2 days of didactic content and several days of brief, real-life skills practice and reporting taking approximately 10-15 minutes to complete. Adolescents and young adults cannot skip ahead, but they can return to old lessons or exercises if they choose. Most exercises are done in a diary format in which past responses are displayed next to their new ones, so that every time they visit that exercise they see their growing list of past positive experiences. Participants will be permitted up to 8 weeks to complete this self-guided intervention.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: EMPOWER
Description: Participants will receive weekly material for a total of 5 weeks consisting of 1-2 days of didactic content and several days of brief, real-life skills practice and reporting taking approximately 10-15 minutes to complete. Adolescents and young adults cannot skip ahead, but they can return to old lessons or exercises if they choose. Most exercises are done in a diary format in which past responses are displayed next to their new ones, so that every time they visit that exercise they see their growing list of past positive experiences. Participants will be permitted up to 8 weeks to complete this self-guided intervention.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: EMPOWER
Description: Participants will receive weekly material for a total of 5 weeks consisting of 1-2 days of didactic content and several days of brief, real-life skills practice and reporting taking approximately 10-15 minutes to complete. Adolescents and young adults cannot skip ahead, but they can return to old lessons or exercises if they choose. Most exercises are done in a diary format in which past responses are displayed next to their new ones, so that every time they visit that exercise they see their growing list of past positive experiences. Participants will be permitted up to 8 weeks to complete this self-guided intervention.
Study: NCT05771168

Intervention type: DEVICE
Intervention: Artificial urinary sphincter
Description: Implantation of peri-urethral artificial urinary sphincter

Intervention type: DEVICE
Intervention: Male sling
Description: Retrourethral implantation of male sling
Study: NCT04317417

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: EMPOWER
Description: Participants will receive weekly material for a total of 5 weeks consisting of 1-2 days of didactic content and several days of brief, real-life skills practice and reporting taking approximately 10-15 minutes to complete. Adolescents and young adults cannot skip ahead, but they can return to old lessons or exercises if they choose. Most exercises are done in a diary format in which past responses are displayed next to their new ones, so that every time they visit that exercise they see their growing list of past positive experiences. Participants will be permitted up to 8 weeks to complete this self-guided intervention.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: EMPOWER
Description: Participants will receive weekly material for a total of 5 weeks consisting of 1-2 days of didactic content and several days of brief, real-life skills practice and reporting taking approximately 10-15 minutes to complete. Adolescents and young adults cannot skip ahead, but they can return to old lessons or exercises if they choose. Most exercises are done in a diary format in which past responses are displayed next to their new ones, so that every time they visit that exercise they see their growing list of past positive experiences. Participants will be permitted up to 8 weeks to complete this self-guided intervention.
Study: NCT05906238

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: STEREOBES Workshops
Description: These workshops are designed to help patients develop appropriate behaviors to deal with stigmatizing situations. They will focus on three main areas: adapted physical activities, nutrition and mental well-being. They will include sessions on developing self-esteem, improving body image and managing emotions. The aim will be to deconstruct the myths and stereotypes surrounding obesity.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Un Poids en moins
Description: Standard intervention proposed by La Vie la Santé
Study: NCT06402773

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: The Signati Separo™ Vessel Sealing System
Description: Vessel Sealing System
Study: NCT06559657

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: eKare Insight, imitoMeasure Mobile App, Visitrak
Description: The wound size of the patients was measured with three different methods. Wound depth was measured using manual method and three-dimensional imaging devices.
Study: NCT06331715

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Palbociclib 125mg
Description: Pharmacokinetic parameters AUC and Cmax will be evaluated to establish bioequivalence betweeen the Test and Reference products

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Palbociclib 125mg
Description: Pharmacokinetic parameters AUC and Cmax will be evaluated to establish bioequivalence betweeen the Test and Reference products
Study: NCT05167487

Intervention type: DRUG
Intervention: Cisplatin
Description: Route of administration: Intravenous infusion. Neoadjuvant chemotherapy is often given 2 to 4 months before surgery.

Intervention type: DRUG
Intervention: Carboplatin
Description: Route of administration: Intravenous infusion. Neoadjuvant chemotherapy is often given 2 to 4 months before surgery.
Study: NCT06560983

Intervention type: OTHER
Intervention: The investigators are planning to do a observational cohort study, hence won't be doing any intervention.
Description: The investigators won't be doing any intervention since this is an observational study.
Study: NCT04987216

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: IOL implantation experimental
Description: Mono- or bilateral implantation of toric intraocular lenses PODEYE TORIC. If only one eye qualifies for toric lens implantation due to small amount of pre-existing corneal astigmatism, one eye will be implanted with PODEYE TORIC and the contralateral eye will be receive an implantation with the monofocal parent lens PODEYE (PhysIOL sa/nv, Liège, Belgium).
Study: NCT06457308

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Physical training of agility
Description: A grouped training for older adults in the community. The training classed lasted for 12 weeks, one session a week for 120 mins, and are under instructed by a trained experienced sport instructor. Use rope ladders and cones to perform multiple tasks of direction changes, acceleration and deceleration of footsteps, hand and foot coordination and spatial orientation training,

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Physical training of resistance
Description: A grouped training for older adults in the community. The training classed lasted for 12 weeks, one session a week for 120 mins, and are under instructed by a trained experienced sport instructor. Resistance training for upper and lower limb muscles and core muscles, including squats, use of elastic bands, and simple bars
Study: NCT05799677

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Reflexology
Description: Additive reflexology treatment
Study: NCT04129970

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Intermittent Theta Burst Stimulation
Description: iTBS will be delivered to the left dorsolateral prefrontal cortex (DLPFC) at 80% of resting motor threshold using standard stimulation parameters; triplet-bursts will be delivered at high frequency (50 Hz) with an inter-burst interval of 200 ms. Each TBS train will last 2 seconds and consists of 10 triplet-bursts (30 pulses). Each iTBS session will involve 10 TBS trains repeated every 10 seconds for 190 seconds, with a total number of 600 pulses delivered during each session.
Study: NCT05340660

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: [ 18 F]PSS232
Description: \[ 18 F\]PSS232 for imaging metabotropic glutamate receptor subtype 5 and comparing expression of the receptor in healthy persons and ALS patients
Study: NCT06183684

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Laplace TTVR System
Description: Transcatheter Tricuspid Valve Replacement (TTVR) System for the treatment of severe, symptomatic tricuspid regurgitation
Study: NCT05259657

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Lymfit Intervention
Description: Participants will be allocated a pre-registered Inspire II / Charge IV model Fitbit. The research team will reach out to the participant via videoconferencing and help them to: download the Fitbit smartphone application; log-in using the anonymous study identification information; and pair their Fitbit with their smartphone application.~A kinesiologist of the study will meet with the participants for a baseline fitness assessment. The kinesiologist will examine the baseline physical activity levels, fitness level and sedentary behaviours of the participants, to design a personalized exercise prescription. Within one week after the baseline fitness assessment, the kinesiologist will contact the participants to discuss the exercise prescription. Every two weeks there-after, the kinesiologist will follow up with the participants via videoconferencing to discuss their progress and to modify or advance their exercise prescriptions as needed, plus an acceptability assessment survey.

Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Wait-list control
Description: Participants will be contacted by the study kinesiologist for a baseline fitness assessment 3 months after they consent, participants will be given a Fitbit, a personalized exercise prescription and receive bi-weekly follow-ups for 12 weeks.
Study: NCT06563141

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: traction and mobilization
Description: The patient undergoes a 15-minute infrared therapy session, followed by flexibility and stretching exercises targeting the trunk and four extremities muscles. Land manipulation techniques are used for cervical, dorsal, and lumbar spine to assess and treat spinal dysfunctions. Deep breathing exercises with rib mobilization are also performed to promote respiratory function and thoracic flexibility. The session aims to improve overall health.
Study: NCT04872270

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Total Shoulder Arthroplasty
Description: Participant will have total shoulder replacement

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Total Shoulder Arthroplasty
Description: Participant will have total shoulder replacement

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Caffeine Pill
Description: 2 week supply of 1000 mg caffeine given postoperatively as part of the pain regimen

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Percocet 10Mg-325Mg Tablet
Description: given postoperatively as standard post-op pain management

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Percocet 10Mg-325Mg Tablet
Description: given postoperatively as standard post-op pain management
Study: NCT05373966

Intervention type: OTHER
Intervention: Delphi Questionnaire
Description: An invitation email, including a link to the survey, will be sent to the panel of experts in the field of robotic RNU. The Delphi questionnaire will be administered via Welphi.com.~In the first survey, panel members will outline the training program for robotic RNU.~In subsequent surveys, the expert panel will evaluate the modified criteria using a 1 to 5-point Likert scale with space provided for suggested edits and comments. Multiple rounds will be conducted until consensus is reached. After each round of Likert responses, the study team will calculate the agreement and distribution of responses. Likert responses will be dichotomized with positive values indicating agreement and neutral or negative values indicating disagreement.~For the questions that do not reach a consensus of more than 80% in the first round or need further explanation, additional rounds of the survey may be performed.
Study: NCT05552495

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CKD-386(4) F1
Description: 1 Tablet

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CKD-386(4) F1
Description: 1 Tablet

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CKD-386(4) F1
Description: 1 Tablet
Study: NCT04995835

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cefiderocol
Description: After receipt of Cefiderocol, blood samples will be collected at various time points to determine the pharmacokinetics of Cefiderocol
Study: NCT05484063

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Multicomponent, mobility-focused intervention
Description: The intervention group will receive early therapist review (within one working day of admission to HOME unit), to be mobilised at least three times a day. They will also receive additional group exercise therapy sessions, as well as nurse screening for geriatric syndromes. Besides that, they will be screened for 4Ms (Mobility, Mentation, Medication, What Matters) by doctor on admission.
Study: NCT05340400

Intervention type: OTHER
Intervention: ROME IV Criteria
Description: Collaborators will use Rome IV criteria for diagnosing IBS by the presence of the abdominal pain at least once a week in the last 3 months, in addition to at least two of the following: abdominal pain related to defecation, change in stool frequency, or shape.

Intervention type: OTHER
Intervention: ROME IV Criteria
Description: Collaborators will use Rome IV criteria for diagnosing IBS by the presence of the abdominal pain at least once a week in the last 3 months, in addition to at least two of the following: abdominal pain related to defecation, change in stool frequency, or shape.
Study: NCT06563141

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: active exercise therapy
Description: Patients with adolescent idiopathic scoliosis will receive exercise programs from seven major schools under SOSORT, focusing on realigning the spine, rib cage, shoulders, and pelvis to normal anatomical postures.
Study: NCT04872270

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Zofran 4Mg Tablet
Description: given postoperatively as standard post-op management

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Zofran 4Mg Tablet
Description: given postoperatively as standard post-op management
Study: NCT05552495

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CKD-386(4) F1
Description: 1 Tablet

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CKD-386(4) F1
Description: 1 Tablet

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CKD-386(4) F1
Description: 1 Tablet

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CKD-386(4) F2
Description: 1 Tablet
Study: NCT05921214

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: VAULT Phase 5
Description: This is an input-based vocabulary learning treatment based on principles of statistical learning.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: VAULT Phase 5
Description: This is an input-based vocabulary learning treatment based on principles of statistical learning.
Study: NCT05552495

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CKD-386(4) F2
Description: 1 Tablet

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CKD-386(4) F2
Description: 1 Tablet

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CKD-386(4) F2
Description: 1 Tablet

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CKD-386(4) F2
Description: 1 Tablet

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CKD-386(4) F2
Description: 1 Tablet

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: D013, D326, D337
Description: D013 1 Tablet, D326 1Tablet, D337 1 Tablet

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: D013, D326, D337
Description: D013 1 Tablet, D326 1Tablet, D337 1 Tablet

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: D013, D326, D337
Description: D013 1 Tablet, D326 1Tablet, D337 1 Tablet

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: D013, D326, D337
Description: D013 1 Tablet, D326 1Tablet, D337 1 Tablet

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: D013, D326, D337
Description: D013 1 Tablet, D326 1Tablet, D337 1 Tablet

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: D013, D326, D337
Description: D013 1 Tablet, D326 1Tablet, D337 1 Tablet
Study: NCT04721691

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Epidiolex 100 mg/mL Oral Solution
Description: Epidiolex is a schedule 5 controlled substance that is a colorless to yellow oral liquid solution that is prepackaged into 100mL vials with 5mL syringes for use. It is typically used for the treatment of seizures associated with Lennox-Gastaut syndrome (LGS) or Dravet Syndrome in patients 2 years of age and older.

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo is composed of dehydrated alcohol, sesame seed oil, strawberry flavor, and sucralose.
Study: NCT05041582

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: tDCS
Description: dual tDCS with ipsilesional primary motor cortex (M1) anodal stimulation and contralesional M1 cathodal stimulation, 2 weeks after SSRI treatment
Study: NCT06522165

Intervention type: OTHER
Intervention: Analysis
Description: analysis and review of imaging and clinical data
Study: NCT05247177

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: dexmedetomidine, ketamine co-administration with sevoflurane for general anesthesia
Description: co-administration of sevoflurane, iv. dexmedetomidine and iv. ketamine to maintain a predefined EEG density spectrum array pattern for general anesthesia

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Conventional general anesthesia by administration of sevoflurane alone
Description: Administration of sevoflurane alone to maintain anesthesia with a bispectral index between 40-60
Study: NCT06513715

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Control
Description: This intervention will be made with a placebo

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Jubanine
Description: This intervention will be made with jubanine or prickly pear extract

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Jubanine
Description: This intervention will be made with jubanine or prickly pear extract

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Jubanine
Description: This intervention will be made with jubanine or prickly pear extract
Study: NCT06455618

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: not Indwelling the ureteral stent
Description: Before the end of surgery, the urologist does not Indwell the ureteral stent in the patient's body. The ureteral stent is usually called Double-J Stent.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Indwelling the ureteral stent
Description: Before the end of surgery, the urologist Indwell the ureteral stent in the patient's body. The ureteral stent is usually called Double-J Stent.